Bioequivalence Evaluation of a New and Current Tablet of ASP015K
Clinical trial NCT02531191 · COMPLETED
Trial details
- NCT number
- NCT02531191
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-21
- Primary completion
- 2015-07-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.